Updates

We have advised a company on defending itself against an enforcement action brought by the Netherlands Food and Consumer Product Safety Authority (NVWA).

We have advised several clients, including Dutch Growth Funds, on the structuring and application of government funding and related public-private partnership schemes aimed at stimulating innovation in the life sciences and health sector. Our advice covers the design and structuring of funding schemes, including the formulation of eligibility criteria and subsidy conditions, the establishment of governance frameworks for public-private consortia, and the administrative and legal requirements for the disbursement of government-funded research and development grants.

We have represented clients in complex commercial litigation proceedings, including claims relating to earn-out disputes in the context of corporate transactions in the life sciences sector.

Our firm litigates before the European Court of Justice on a variety of life sciences topics.

Our lawyers have acted as expert in national litigation cases on MDR compliance in other EU Member States.

One of our lawyers has acted as arbiter in international proceedings on MDR compliance.

Our firm is experienced in the conduct and defence of companies against freedom of information cases pertaining to confidential under Dutch and EU law, and has defended a number of companies, including a multinational, in a series of such cases over the years.

We have assisted several clients in challenging tender decisions by Dutch hospitals.

We have litigated in a pharmaceutical case concerning the validity of marketing authorisations.

We have advised several clients on the conduct and defence of complaints made to the Dutch Advertising Committee regarding claims about products such as foods, pharmaceuticals and medical devices across Dutch media.